Data & Analysis
Data & Analysis · page 10
- Data & Analysis
Europe’s €11.4bn Illicit Cannabis Market: Potency Surge, Semi-Synthetics & Staggering Environmental Impacts
Last week the European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) launched its comprehensive report on the EU’s illicit cannabis market.
- CBD Market
Cannabis Costs in Germany: Breaking Down the Numbers for Patients and Practitioners
In Germany, the price of cannabis sold on public prescription is set by the government.
- Data & Analysis
The Global Cannabis Testing Industry Could Be Worth up to $770m by 2027, New Report States
As the cannabis industry continues to expand and evolve at pace throughout the globe, product testing is becoming an increasingly vital subsector.
- Data & Analysis
Portugal Has 42 Licensed Medicinal Cannabis Companies, but Another 150 Are in Process
As reported by Cannareporter Portugal remains well positioned to be one of the main producers of medicinal cannabis in the world.
- Data & Analysis
Growing Media Best Practices for Cannabis
In the first of a series of articles from international agritech company Premier Tech, we delve into which growing mediums will enable cannabis cultivators to achieve the best yields.
- Data & Analysis
Growing Media Best Practices for Cannabis
In the first of a series of articles from international agritech company Premier Tech, we delve into which growing mediums will enable cannabis cultivators to achieve the best yields.
- Adult-Use
First Mover States Saw Greatest Economic Benefits of Legalising Cannabis
This Nov 3rd, join us for the third edition of Business of Cannabis: New York at The Williamsburg Hotel.
- Data & Analysis
Denmark’s Medical Cannabis Pilot Programme Has Seen 90% Growth Over the Last Year
Denmark’s medical cannabis Pilot Programme has seen patient numbers grow by more than 90% between Q2 2022 and Q2 2023.
- Data & Analysis
Navigating the Italian Medical Cannabis Landscape: A Comprehensive Guide
Introduction In the realm of medical cannabis, Italy has been progressively establishing its regulatory framework to facilitate access and enable the use of cannabis-based treatments.
- Data & Analysis
Pharmaceutical Cannabis Players Are Driving Technological Innovation Across The Value Chain
The slow but steady march of pharmaceutical players into the cannabis industry has spurned a new period of technological innovation, bringing new techniques and technologies to every part of the cannabis value chain.
- Data & Analysis
Canadian Medical Cannabis Exports Jump 50% Amid Decreasing Domestic Sales
Canadian cannabis companies are increasingly turning to the international medical cannabis market, seeing exports increase by 50% last year.
- Data & Analysis
Pharma Industry Showing ‘Growing Interest’ in Cannabis as M&A Activity Increases
Big pharma has so far been cautious of diving headfirst into the cannabis industry, despite the growing body of evidence surrounding its medical benefits.
